EarningsQ4 2022 Earnings Report

Novavax (NVAX) Q4 2022 Earnings Report

0 Followers

MX:NVAX Q4 2022 EPS Results

Actual EPS-$41.62

Consensus EPS-$18.51

Beat/MissMissed by -$23.11

One Year Ago EPS-$204.09

Actual Revenue$6.52B

Expected Revenue$6.99B

Beat/MissMissed by -$469.94M

YoY Revenue Growth+60.85%

QuarterQ4 2022

Date02/28/2023

TimeAfter Close

Conference CallTuesday, February 28, 2023

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q4 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-3.94 / -	-22.818	―
Aug 06, 2026	2026 (Q2)	-6.94 / -5.84	11.318	-151.61% (-17.16)
May 06, 2026	2026 (Q1)	-4.42 / -1.10	53.486	-102.05% (-54.58)
Feb 26, 2026	2025 (Q4)	-8.85 / 2.01	-9.31	121.57% (+11.32)
Nov 06, 2025	2025 (Q3)	-21.83 / -22.82	-13.873	-64.47% (-8.94)
Aug 06, 2025	2025 (Q2)	0.15 / 11.32	18.072	-37.37% (-6.75)
May 08, 2025	2025 (Q1)	-7.72 / 53.49	-19.167	379.05% (+72.65)
Feb 27, 2025	2024 (Q4)	-9.38 / -9.31	-26.286	64.58% (+16.98)
Nov 12, 2024	2024 (Q3)	-14.44 / -13.87	-23.001	39.68% (+9.13)
Aug 08, 2024	2024 (Q2)	30.49 / 18.07	10.588	70.69% (+7.48)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed